Martin v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided March 1, 2021·No. 15-789·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 15-789V (not to be published)

************************* LINDSEY MARTIN and RAYNARD * Chief Special Master Corcoran MARTIN, as representatives of the estate of * I.R.M., deceased, * * Filed: December 8, 2020 Petitioners, * * Attorney’s Fees and Costs; v. * Final Fees Award; * Reasonable Basis; Expert SECRETARY OF HEALTH AND * Rates; Reductions HUMAN SERVICES, * * Respondent. * * *************************

Richard Gage, Richard Gage, P.C., Cheyenne, WY, for Petitioner.

Julia M. Collison, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION AWARDING ATTORNEY’S FEES AND COSTS 1

On July 27, 2015, Lindsay and Raynard Martin filed a Petition under the National Vaccine Injury Compensation Program (the “Vaccine Program” 2), on behalf of their deceased son, I.R.M., alleging that the Flumist version of the influenza (“flu”) vaccine he received on September 24, 2014, caused his death two days later. Pet. at 1-2 (ECF No. 1). A hearing in this matter was held on May 23–24, 2019, and I subsequently issued a decision denying entitlement. ECF No. 85.

1 Although the Decision has not formally been designated for publication, it will nevertheless be posted on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 (2012). This means the Decision will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa- 12(d)(4)(B), however, the parties may object to the published Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the entire Decision will be available to the public in its current form. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter “Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the pertinent subparagraph of 42 U.S.C. § 300aa. Petitioners filed a motion for review that was denied (ECF No. 97), and they did not pursue further appeal.

Petitioners have now filed a motion for a final award of attorney’s fees and costs. Motion, filed Nov. 13, 2020 (ECF No. 101) (“Fees App.”). Petitioners request $209,931.28—$109,066.71 in attorney’s fees and $100,864.57 in costs—for the work of attorneys Mr. Richard Gage, Ms. Kristen Blume, and various paralegals. Fees App. at 4. Petitioners also seek fees for Ms. Valerie Borek, Esq., the attorney who initially represented them in this matter prior to Mr. Gage’s appearance. Id. at 101-114. The costs requested include fees for three experts, record retrieval, shipping, and travel expenses for counsel and experts associated with the case’s trial. Id. at 4. Respondent reacted to the fees request on December 4, 2020. See Response (ECF No. 102). Respondent is satisfied that the statutory requirements for an attorney’s fees and costs award are met in this case, and otherwise defers to my discretion the calculation of a proper amount to be awarded. Response at 2, 3.

ANALYSIS

I. Petitioners’ Claim had Reasonable Basis

Under the Vaccine Act, a special master may award fees and costs to an unsuccessful petitioner if: (1) the “petition was brought in good faith”; and (2) “there was a reasonable basis for the claim for which the petition was brought.” Section 15(e)(1). I have in prior decisions set forth at length the criteria to be applied when determining if a claim possessed “reasonable basis” sufficient for a fees award. See, e.g., Sterling v. Sec’y of Health & Hum. Servs., No. 16-551V, 2020 WL 549443, at *4 (Fed. Cl. Spec. Mstr. Jan. 3, 2020). In short, the claim’s reasonable basis must be demonstrated through some objective evidentiary showing. Cottingham v. Sec’y of Health & Hum. Servs., 971 F.3d 1337, 1344 (Fed. Cir. 2020) (citing Simmons v. Sec’y of Health & Hum. Servs., 875 F.3d 632, 635 (Fed. Cir. 2017)).

This objective inquiry is focused on the claim—counsel’s conduct is irrelevant (although it may bulwark good faith). Simmons, 875 F.3d at 635. Reasonable basis inquiries are not static— they evaluate not only what was known at the time the petition was filed, but also take into account what is learned about the evidentiary support for the claim as the matter progresses. Perreira v. Sec’y of Health & Hum. Servs., 33 F.3d 1375, 1377 (Fed. Cir. 1994) (upholding the finding that a reasonable basis for petitioners’ claims ceased to exist once they had reviewed their expert's opinion, which consisted entirely of unsupported speculation).

The standard for reasonable basis is lesser (and thus inherently easier to satisfy) than the preponderant standard applied when assessing entitlement, as cases that fail can still have sufficient objective grounding for a fees award. Braun v. Sec’y of Health & Hum. Servs., 144 Fed.

2 Cl. 72, 77 (2019). Under the Vaccine Act, special masters have “maximum discretion” in applying the reasonable basis standard. See, e.g., Silva v. Sec’y of Health & Hum. Servs., 108 Fed. Cl. 401, 401–02 (Fed. Cl. 2012). The Court of Federal Claims has affirmed that “[r]easonable basis is a standard that petitioners, at least generally, meet by submitting evidence.” Chuisano v. Sec’y of Health & Hum. Servs., 116 Fed. Cl. 276, 287 (2014) (internal quotations omitted) (affirming special master). The factual basis and medical support for the claim is among the evidence that should be considered. Carter v. Sec’y of Health & Hum. Servs., 132 Fed. Cl. 372, 378 (2017).

I determined in my entitlement decision that Petitioners had not established by preponderant evidence that the flu vaccine caused I.R.M.’s tragic death or could have done so. However, their claim had sufficient objective basis to justify a fees and costs award. There was no dispute about the fact of vaccination or general circumstances of I.R.M.’s death, which occurred close enough in time to the vaccine’s administration to raise reasonable questions about a possible association. The experts also agreed in critical respects on certain matters relevant to my disposition of the claim, further bulwarking the objective reasonableness of Petitioners’ position. And although I was not ultimately persuaded by Petitioners’ causation theory, it was supported by credible science and contained many reliable sub-components. Respondent for his part does not otherwise contest reasonable basis. Accordingly, a final award of fees and costs in this matter is appropriate.

II. Calculation of Attorney Fees

Determining the appropriate amount of the fees award is a two-part process.

Free access — add to your briefcase to read the full text and ask questions with AI

Martin v. Secretary of Health and Human Services, (uscfc 2021).

Martin v. Secretary of Health and Human Services (Martin v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related